石藥集團(01093.HK): 「利格列汀片」獲藥品註冊批件 2021-05-25T10:39:22-04:00May 25th, 2021| share this article!【財華社訊】石藥集團(01093.HK)公佈,附屬公司開發的「利格列汀片(5mg)」已獲得國家藥品監督管理局頒發藥品註冊批件,並視同通過仿製藥質量和療效一致性評價。 Read More share this article! Related Posts Malaysian PE firm Ekuinas acquires 80% stake in pharma player Symbiotica May 3rd, 2024 China’s BYD, Neta eye growth in Indonesia with new EV investments May 3rd, 2024 Nippon Steel postpones U.S. Steel buyout to after presidential race May 3rd, 2024 Collapsed US lender SVB Financial to sell venture capital business May 3rd, 2024